# 2026-23668: FDA Explains How Medical Device Clearances Change Hands

2026-23668, Transfer of a Premarket Notification (510(k)) Clearance-Questions and Answers; Guidance for Industry and Food and Drug Administration Staff; Availability, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-11-20, effective 2026-11-20; PRIA reads it as touching household money (as of 2026-11-20).

- Canonical: https://policyrisk.com/federal-register/2026-23668
- As of: 2026-11-20
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-23668
- Title: Transfer of a Premarket Notification (510(k)) Clearance-Questions and Answers; Guidance for Industry and Food and Drug Administration Staff; Availability
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 75334
- Published: 2026-11-20
- Effective: 2026-11-20
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-11-20

## In one line

FDA Explains How Medical Device Clearances Change Hands

## Summary

The FDA just released clear answers about how companies can transfer their 510(k) medical device approvals to new owners. This helps businesses understand the rules when selling or buying these clearances, making the process smoother and more predictable. The guidance is effective immediately and doesn’t add new costs but helps avoid confusion and delays.

## Abstract

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance titled "Transfer of a Premarket Notification (510(k)) Clearance--Questions and Answers." This guidance provides information on the most frequently asked questions regarding the transfer or sale of a 510(k) clearance from one 510(k) holder to another.

## Effects PRIA read

- New 510(k) holder must register and list: cost, medium. If you buy or receive a 510(k) clearance and you are engaged in manufacturing or other listed operations, you must register and list the device in FDA’s electronic registration and listing system. You must register within 30 days after entering into those operations and include the FDA-assigned cle…
- Significant changes trigger a new 510(k): cost, medium. If the new 510(k) holder significantly changes the device’s design, components, manufacturing method, or intended use, the new holder must generally submit a new 510(k). After clearance of that new 510(k), the holder must list the device using the new FDA-assigned premarket submission number.
- Labeler must update GUDID promptly: cost, low. If the labeler information (for example, the name of the labeler) changes when a 510(k) clearance transfers, the labeler must submit an update to the Global Unique Device Identification Database (GUDID). The update must be submitted no later than the date the device is first labeled with the change…
- Noncompliance can render a device adulterated or misbranded: cost, high. If you fail to register, list, update GUDID information, or submit a required marketing application, FDA states your device may be considered adulterated and/or misbranded under the Federal Food, Drug, and Cosmetic Act.
- Guidance adds no new paperwork collections: benefit, low. FDA says this guidance contains no new collection of information under the Paperwork Reduction Act and instead refers to previously approved information collections (for example, OMB control numbers 0910-0120 and 0910-0625).
- Guidance clarifies transfer rules and terminology: benefit, low. FDA revised the guidance after public comments to clarify terminology and further explain 510(k) holder requirements related to the sale or transfer of a 510(k) clearance. The guidance provides Frequently Asked Questions to explain when a new 510(k) is needed and how to list transferred devices.

## Related documents

- [2026-23351](https://policyrisk.com/federal-register/2026-23351): Rulemaking To Provide That N-acetyl-L-cysteine Is Not Excluded From the Dietary Supplement Definition, 2026-11-17
- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-14967](https://policyrisk.com/federal-register/2025-14967): Requirements for Additional Traceability Records for Certain Foods: Compliance Date Extension, 2025-08-07

## Sources
- [2026-23668 on federalregister.gov](https://www.federalregister.gov/documents/2026/11/20/2026-23668/transfer-of-a-premarket-notification-510k-clearance-questions-and-answers-guidance-for-industry-and)
- [2026-23668 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-11-20/pdf/2026-23668.pdf)

## Related
- [Previous: 2026-23666, Notice of Lodging of Proposed Consent Decree Under the Safe Drinking Water Act](https://policyrisk.com/federal-register/2026-23666)
- [Next: 2026-23670, Empire Pipeline, Inc.; Notice Of Filing](https://policyrisk.com/federal-register/2026-23670)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-23668 (as of 2026-11-20).
